RecruitingNot ApplicableNCT06918067

Comparison of Urinary Flow Study

Comparison of Urinary Flow Speed Using 14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter Versus 14 Fr Coloplast Micro Zone Luja Female Catheter in Female Patients Using Intermittent Catheters


Sponsor

Wake Forest University Health Sciences

Enrollment

17 participants

Start Date

Nov 6, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research study is to compare the urinary flow speed of two different female catheters in patients that use intermittent catheters to empty their bladder. The "14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter" will be compared to the "14 Fr Coloplast Micro Zone Luja Female Catheter." Participants will have one study visit that should take about an hour and will also receive a follow-up telephone call about one week after the visit.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Coloplast Micro Zone Luja Female Catheter and a medical device called Coloplast SpeediCath Female Catheter for people with urinary retention. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEColoplast Micro Zone Luja Female Catheter

clean self-catheterization with 14 Fr Coloplast micro zone Luja female urinary catheter

DEVICEColoplast SpeediCath Female Catheter

clean self-catheterization with 14 Fr two eyelet Coloplast SpeediCath female urinary catheter


Locations(1)

Women's Center for Pelvic Health (Mercy)

Charlotte, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06918067


Related Trials